The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was named:
"Erythroid Transcription Factor GATA-1, subunit A
".
FunFam 9: nuclear receptor subfamily 4 group A member 2
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 49 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
47 |
F1D8N6 (/IPI)
F1D8N6 (/IPI)
F1D8N6 (/IPI)
F1D8N6 (/IPI)
F1D8N6 (/IPI)
F1D8N6 (/IPI)
F1D8N6 (/IPI)
F1D8N6 (/IPI)
F1D8N6 (/IPI)
F1D8N6 (/IPI)
(37 more) |
Nuclear receptor activity GO:0004879
Combining with a signal and transmitting the signal to the transcriptional machinery by interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II.
|
25 |
P22736 (/TAS)
P22736 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(15 more) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
25 |
P22736 (/ISS)
P22736 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
(15 more) |
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
24 |
P22736 (/ISS)
P22736 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
(14 more) |
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
22 |
P22736 (/ISA)
P22736 (/ISA)
P43354 (/ISA)
P43354 (/ISA)
P43354 (/ISA)
P43354 (/ISA)
P43354 (/ISA)
P43354 (/ISA)
P43354 (/ISA)
P43354 (/ISA)
(12 more) |
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
22 |
P22736 (/ISM)
P22736 (/ISM)
P43354 (/ISM)
P43354 (/ISM)
P43354 (/ISM)
P43354 (/ISM)
P43354 (/ISM)
P43354 (/ISM)
P43354 (/ISM)
P43354 (/ISM)
(12 more) |
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
22 |
P22736 (/NAS)
P22736 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
(12 more) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
21 |
P22736 (/TAS)
P22736 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(11 more) |
Beta-catenin binding GO:0008013
Interacting selectively and non-covalently with the beta subunit of the catenin complex.
|
18 |
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(8 more) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
18 |
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(8 more) |
Retinoid X receptor binding GO:0046965
Interacting selectively and non-covalently with a retinoid X receptor.
|
18 |
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(8 more) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
18 |
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(8 more) |
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
10 | P12813 (/IDA) P12813 (/IDA) P22829 (/IDA) P51179 (/IDA) Q06219 (/IDA) Q06219 (/IDA) Q07917 (/IDA) Q92570 (/IDA) Q92570 (/IDA) Q9QZB6 (/IDA) |
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
|
7 | P12813 (/IDA) P12813 (/IDA) P41829 (/IDA) Q06219 (/IDA) Q06219 (/IDA) Q07917 (/IDA) Q9QZB6 (/IDA) |
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
5 | P12813 (/ISO) P12813 (/ISO) Q06219 (/ISO) Q06219 (/ISO) Q9QZB6 (/ISO) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
5 | P12813 (/IDA) P12813 (/IDA) P51179 (/IDA) Q06219 (/IDA) Q06219 (/IDA) |
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
|
4 | Q06219 (/IDA) Q06219 (/IDA) Q07917 (/IDA) Q9QZB6 (/IDA) |
Glucocorticoid receptor binding GO:0035259
Interacting selectively and non-covalently with a glucocorticoid receptor.
|
4 | P22829 (/IPI) P51179 (/IPI) Q06219 (/IPI) Q06219 (/IPI) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
4 | P12813 (/IPI) P12813 (/IPI) Q06219 (/IPI) Q06219 (/IPI) |
Glucocorticoid receptor binding GO:0035259
Interacting selectively and non-covalently with a glucocorticoid receptor.
|
3 | P12813 (/ISO) P12813 (/ISO) Q9QZB6 (/ISO) |
CAMP response element binding GO:0035497
Interacting selectively and non-covalently with the cyclic AMP response element (CRE), a short palindrome-containing sequence found in the promoters of genes whose expression is regulated in response to cyclic AMP.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
3 | P12813 (/IDA) P12813 (/IDA) P51179 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
3 | Q92570 (/ISS) Q92570 (/ISS) Q9QZB6 (/ISS) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
3 | P22829 (/IDA) Q06219 (/IDA) Q06219 (/IDA) |
RNA polymerase II regulatory region sequence-specific DNA binding GO:0000977
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
|
2 | Q06219 (/ISO) Q06219 (/ISO) |
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
2 | P22736 (/ISS) P22736 (/ISS) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
2 | Q92570 (/NAS) Q92570 (/NAS) |
Steroid hormone receptor activity GO:0003707
Combining with a steroid hormone and transmitting the signal within the cell to initiate a change in cell activity or function.
|
2 | Q92570 (/TAS) Q92570 (/TAS) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
2 | P12813 (/ISO) P12813 (/ISO) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
2 | Q92570 (/IPI) Q92570 (/IPI) |
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
|
2 | Q06219 (/ISO) Q06219 (/ISO) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
2 | P12813 (/ISO) P12813 (/ISO) |
RNA polymerase II regulatory region sequence-specific DNA binding GO:0000977
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.
|
1 | P49869 (/IDA) |
Core promoter binding GO:0001047
Interacting selectively and non-covalently with the regulatory region composed of the transcription start site and binding sites for the basal transcription machinery. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
|
1 | P49869 (/IMP) |
Transcription coactivator binding GO:0001223
Interacting selectively and non-covalently with a transcription coactivator, any protein involved in positive regulation of transcription via protein-protein interactions with transcription factors and other proteins that positively regulate transcription. Transcription coactivators do not bind DNA directly, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery.
|
1 | Q9QZB6 (/IPI) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
1 | Q9QZB6 (/ISO) |
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
|
1 | P41829 (/IDA) |
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
|
1 | Q07917 (/TAS) |
Nuclear receptor activity GO:0004879
Combining with a signal and transmitting the signal to the transcriptional machinery by interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II.
|
1 | P49869 (/NAS) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | P49869 (/IPI) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
1 | P22829 (/IPI) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
1 | Q9QZB6 (/ISO) |
Histone acetyltransferase binding GO:0035035
Interacting selectively and non-covalently with the enzyme histone acetyltransferase.
|
1 | Q9QZB6 (/IPI) |
CAMP response element binding GO:0035497
Interacting selectively and non-covalently with the cyclic AMP response element (CRE), a short palindrome-containing sequence found in the promoters of genes whose expression is regulated in response to cyclic AMP.
|
1 | Q9QZB6 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | Q9QZB6 (/ISO) |
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
|
1 | P49869 (/IMP) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
1 | P49869 (/IMP) |
There are 153 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Fat cell differentiation GO:0045444
The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat.
|
29 |
P22736 (/ISS)
P22736 (/ISS)
P22829 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
(19 more) |
Cellular response to corticotropin-releasing hormone stimulus GO:0071376
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticotropin-releasing hormone stimulus. Corticotropin-releasing hormone is a peptide hormone involved in the stress response.
|
29 |
P22736 (/ISS)
P22736 (/ISS)
P22829 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
(19 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
23 |
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
(13 more) |
Transcription initiation from RNA polymerase II promoter GO:0006367
Any process involved in the assembly of the RNA polymerase II preinitiation complex (PIC) at an RNA polymerase II promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription.
|
22 |
P22736 (/TAS)
P22736 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(12 more) |
Dopaminergic neuron differentiation GO:0071542
The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
|
21 |
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
P43354 (/ISS)
(11 more) |
Transcription, DNA-templated GO:0006351
The cellular synthesis of RNA on a template of DNA.
|
20 |
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
(10 more) |
Cellular response to extracellular stimulus GO:0031668
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an extracellular stimulus.
|
20 |
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
P43354 (/IDA)
(10 more) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
18 |
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
(8 more) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
18 |
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(8 more) |
Neuron migration GO:0001764
The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature.
|
18 |
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(8 more) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
18 |
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
P43354 (/NAS)
(8 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
18 |
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(8 more) |
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
|
18 |
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(8 more) |
Midbrain dopaminergic neuron differentiation GO:1904948
The process in which a relatively unspecialized cell acquires the specialized features of a midbrain dopaminergic neuron.
|
18 |
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(8 more) |
Negative regulation of apoptotic signaling pathway GO:2001234
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway.
|
18 |
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
P43354 (/IMP)
(8 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
13 |
P12813 (/IDA)
P12813 (/IDA)
P22736 (/IDA)
P22736 (/IDA)
P22829 (/IDA)
P41829 (/IDA)
P51179 (/IDA)
Q06219 (/IDA)
Q06219 (/IDA)
Q07917 (/IDA)
(3 more) |
Regulation of type B pancreatic cell proliferation GO:0061469
Any process that modulates the frequency, rate or extent of type B pancreatic cell proliferation.
|
9 | P12813 (/ISS) P12813 (/ISS) P22736 (/ISS) P22736 (/ISS) P51666 (/ISS) Q0V8F0 (/ISS) Q92570 (/ISS) Q92570 (/ISS) Q9QZB6 (/ISS) |
Neutrophil homeostasis GO:0001780
The process of regulating the proliferation and elimination of neutrophils such that the total number of neutrophils within a whole or part of an organism is stable over time in the absence of an outside stimulus.
|
7 | A0A2R8RWF0 (/IGI) A0A2R9YJF7 (/IGI) A9Q8C8 (/IGI) F1QK43 (/IGI) F1RER4 (/IGI) I6LBI6 (/IGI) Q6DH08 (/IGI) |
Forebrain neuron development GO:0021884
The process whose specific outcome is the progression of a neuron that resides in the forebrain, from its initial commitment to its fate, to the fully functional differentiated cell.
|
7 | A0A2R8RWF0 (/IMP) A0A2R9YJF7 (/IMP) A9Q8C8 (/IMP) F1QK43 (/IMP) F1RER4 (/IMP) I6LBI6 (/IMP) Q6DH08 (/IMP) |
Dopaminergic neuron differentiation GO:0071542
The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
|
7 | A0A2R8RWF0 (/IGI) A0A2R9YJF7 (/IGI) A9Q8C8 (/IGI) F1QK43 (/IGI) F1RER4 (/IGI) I6LBI6 (/IGI) Q6DH08 (/IGI) |
Central nervous system neuron differentiation GO:0021953
The process in which a relatively unspecialized cell acquires specialized features of a neuron whose cell body resides in the central nervous system.
|
6 | A0A2R8RWF0 (/IMP) F1QK43 (/IMP) I6LBI6 (/IMP) Q06219 (/IMP) Q06219 (/IMP) Q6DH08 (/IMP) |
Fat cell differentiation GO:0045444
The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat.
|
5 | P12813 (/IDA) P12813 (/IDA) Q06219 (/IDA) Q06219 (/IDA) Q9QZB6 (/IDA) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
5 | P22736 (/ISS) P22736 (/ISS) P22829 (/ISS) P51666 (/ISS) Q0V8F0 (/ISS) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
5 | P12813 (/IDA) P12813 (/IDA) Q06219 (/IDA) Q06219 (/IDA) Q9QZB6 (/IDA) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
5 | P12813 (/IGI) P12813 (/IGI) Q06219 (/IGI) Q06219 (/IGI) Q9QZB6 (/IGI) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
5 | P12813 (/ISO) P12813 (/ISO) Q06219 (/ISO) Q06219 (/ISO) Q9QZB6 (/ISO) |
Cellular response to corticotropin-releasing hormone stimulus GO:0071376
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticotropin-releasing hormone stimulus. Corticotropin-releasing hormone is a peptide hormone involved in the stress response.
|
5 | P12813 (/IDA) P12813 (/IDA) Q06219 (/IDA) Q06219 (/IDA) Q9QZB6 (/IDA) |
Neutrophil homeostasis GO:0001780
The process of regulating the proliferation and elimination of neutrophils such that the total number of neutrophils within a whole or part of an organism is stable over time in the absence of an outside stimulus.
|
4 | A0A0R4IMQ4 (/IMP) F1R8N1 (/IMP) I6LBI4 (/IMP) Q1L695 (/IMP) |
Response to inorganic substance GO:0010035
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inorganic substance stimulus.
|
4 | P12813 (/ISO) P12813 (/ISO) Q06219 (/ISO) Q06219 (/ISO) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Transcription, DNA-templated GO:0006351
The cellular synthesis of RNA on a template of DNA.
|
3 | Q07917 (/ISS) Q08E53 (/ISS) Q5R5Y4 (/ISS) |
Gastrulation GO:0007369
A complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals. The details of gastrulation vary from species to species, but usually result in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Pyruvate oxidation GO:0009444
The chemical reactions and pathways resulting in the conversion of pyruvate to acetylphosphate.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Positive regulation of cardiac muscle hypertrophy GO:0010613
Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
|
3 | Q92570 (/ISS) Q92570 (/ISS) Q9QZB6 (/ISS) |
Central nervous system neuron differentiation GO:0021953
The process in which a relatively unspecialized cell acquires specialized features of a neuron whose cell body resides in the central nervous system.
|
3 | A0A2R9YJF7 (/IGI) A9Q8C8 (/IGI) F1RER4 (/IGI) |
Central nervous system neuron development GO:0021954
The process whose specific outcome is the progression of a neuron whose cell body is located in the central nervous system, from initial commitment of the cell to a neuronal fate, to the fully functional differentiated neuron.
|
3 | A0A2R9YJF7 (/IMP) A9Q8C8 (/IMP) F1RER4 (/IMP) |
Positive regulation of mast cell cytokine production GO:0032765
Any process that activates or increases the frequency, rate, or extent of mast cell cytokine production.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Common myeloid progenitor cell proliferation GO:0035726
The multiplication or reproduction of common myeloid progenitor cells, resulting in the expansion of a cell population. A common myeloid progenitor cell is a progenitor cell committed to the myeloid lineage.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway GO:0038097
An Fc-epsilon receptor signaling pathway that results in the change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Mast cell degranulation GO:0043303
The regulated exocytosis of secretory granules containing preformed mediators such as histamine, serotonin, and neutral proteases by a mast cell.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
3 | Q06219 (/IMP) Q06219 (/IMP) Q9QZB6 (/IMP) |
Cellular response to leptin stimulus GO:0044320
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Cellular respiration GO:0045333
The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which either requires oxygen (aerobic respiration) or does not (anaerobic respiration).
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Positive regulation of fatty acid oxidation GO:0046321
Any process that activates or increases the frequency, rate or extent of fatty acid oxidation.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Regulation of type B pancreatic cell proliferation GO:0061469
Any process that modulates the frequency, rate or extent of type B pancreatic cell proliferation.
|
3 | P12813 (/ISO) P12813 (/ISO) Q9QZB6 (/ISO) |
Cellular response to catecholamine stimulus GO:0071870
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a catecholamine stimulus. A catecholamine is any of a group of biogenic amines that includes 4-(2-aminoethyl)pyrocatechol
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Energy homeostasis GO:0097009
Any process involved in the balance between food intake (energy input) and energy expenditure.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Positive regulation of monocyte aggregation GO:1900625
Any process that activates or increases the frequency, rate or extent of monocyte aggregation.
|
3 | Q92570 (/IMP) Q92570 (/IMP) Q9QZB6 (/IMP) |
Negative regulation of hydrogen peroxide-induced neuron death GO:1903208
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced neuron death.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Positive regulation of feeding behavior GO:2000253
Any process that activates or increases the frequency, rate or extent of feeding behavior.
|
3 | P51179 (/ISS) Q92570 (/ISS) Q92570 (/ISS) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | Q06219 (/ISO) Q06219 (/ISO) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Neuron migration GO:0001764
The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
2 | P22736 (/IMP) P22736 (/IMP) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
2 | P12813 (/ISO) P12813 (/ISO) |
Response to amphetamine GO:0001975
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Cell migration involved in sprouting angiogenesis GO:0002042
The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.
|
2 | P22736 (/IDA) P22736 (/IDA) |
Cell migration involved in sprouting angiogenesis GO:0002042
The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.
|
2 | P12813 (/ISO) P12813 (/ISO) |
Transcription, DNA-templated GO:0006351
The cellular synthesis of RNA on a template of DNA.
|
2 | Q06219 (/ISO) Q06219 (/ISO) |
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
2 | P12813 (/IMP) P12813 (/IMP) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
2 | P22736 (/TAS) P22736 (/TAS) |
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Adult locomotory behavior GO:0008344
Locomotory behavior in a fully developed and mature organism.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Gene expression GO:0010467
The process in which a gene's sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Positive regulation of glucose transmembrane transport GO:0010828
Any process that increases the frequency, rate or extent of glucose transport across a membrane. Glucose transport is the directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
2 | Q92570 (/IDA) Q92570 (/IDA) |
Positive regulation of glucose transmembrane transport GO:0010828
Any process that increases the frequency, rate or extent of glucose transport across a membrane. Glucose transport is the directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
2 | P51179 (/ISS) Q9QZB6 (/ISS) |
Response to insecticide GO:0017085
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insecticide stimulus. Insecticides are chemicals used to kill insects.
|
2 | Q06219 (/ISO) Q06219 (/ISO) |
Central nervous system projection neuron axonogenesis GO:0021952
Generation of a long process of a CNS neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells in a different central nervous system region.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Habenula development GO:0021986
The progression of the habenula over time from its initial formation until its mature state. The habenula is the group of nuclei that makes up the stalk of the pineal gland.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Neuron differentiation GO:0030182
The process in which a relatively unspecialized cell acquires specialized features of a neuron.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Cellular response to extracellular stimulus GO:0031668
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an extracellular stimulus.
|
2 | Q06219 (/ISO) Q06219 (/ISO) |
Cellular response to oxidative stress GO:0034599
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Endothelial cell chemotaxis GO:0035767
The directed movement of an endothelial cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
|
2 | P22736 (/IMP) P22736 (/IMP) |
Endothelial cell chemotaxis GO:0035767
The directed movement of an endothelial cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
|
2 | P12813 (/ISO) P12813 (/ISO) |
Skeletal muscle cell differentiation GO:0035914
The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle.
|
2 | P12813 (/IMP) P12813 (/IMP) |
Cellular response to vascular endothelial growth factor stimulus GO:0035924
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
|
2 | P22736 (/IMP) P22736 (/IMP) |
Cellular response to vascular endothelial growth factor stimulus GO:0035924
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
|
2 | P12813 (/ISO) P12813 (/ISO) |
Regulation of dopamine metabolic process GO:0042053
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving dopamine.
|
2 | Q06219 (/IDA) Q06219 (/IDA) |
Dopamine biosynthetic process GO:0042416
The chemical reactions and pathways resulting in the formation of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Dopamine metabolic process GO:0042417
The chemical reactions and pathways involving dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Neuron maturation GO:0042551
A developmental process, independent of morphogenetic (shape) change, that is required for a neuron to attain its fully functional state.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | P12813 (/IDA) P12813 (/IDA) |
Positive regulation of catalytic activity GO:0043085
Any process that activates or increases the activity of an enzyme.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
|
2 | P12813 (/IDA) P12813 (/IDA) |
Regulation of respiratory gaseous exchange GO:0043576
Any process that modulates the frequency, rate or extent of the process of gaseous exchange between an organism and its environment.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Cellular response to fibroblast growth factor stimulus GO:0044344
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an fibroblast growth factor stimulus.
|
2 | P22736 (/IMP) P22736 (/IMP) |
Cellular response to fibroblast growth factor stimulus GO:0044344
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an fibroblast growth factor stimulus.
|
2 | P12813 (/ISO) P12813 (/ISO) |
Regulation of megakaryocyte differentiation GO:0045652
Any process that modulates the frequency, rate or extent of megakaryocyte differentiation.
|
2 | Q92570 (/TAS) Q92570 (/TAS) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
2 | P12813 (/IDA) P12813 (/IDA) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Platelet-derived growth factor receptor signaling pathway GO:0048008
The series of molecular signals generated as a consequence of a platelet-derived growth factor receptor binding to one of its physiological ligands.
|
2 | Q92570 (/IDA) Q92570 (/IDA) |
Regulation of smooth muscle cell proliferation GO:0048660
Any process that modulates the frequency, rate or extent of smooth muscle cell proliferation.
|
2 | Q92570 (/IDA) Q92570 (/IDA) |
Regulation of smooth muscle cell proliferation GO:0048660
Any process that modulates the frequency, rate or extent of smooth muscle cell proliferation.
|
2 | P51179 (/ISS) Q9QZB6 (/ISS) |
General adaptation syndrome GO:0051866
General adaptation syndrome is the set of changes in various organ systems of the body, especially the pituitary-endocrine system, in response to a wide range of strong external stimuli, both physiological and psychological. It is described as having three stages: alarm reaction, where the body detects the external stimulus; adaptation, where the body engages defensive countermeasures against the stressor; and exhaustion, where the body begins to run out of defenses.
|
2 | Q06219 (/IMP) Q06219 (/IMP) |
Regulation of type B pancreatic cell proliferation GO:0061469
Any process that modulates the frequency, rate or extent of type B pancreatic cell proliferation.
|
2 | P22829 (/IMP) P51179 (/IMP) |
Cellular response to organic substance GO:0071310
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
2 | P12813 (/IDA) P12813 (/IDA) |
Dopaminergic neuron differentiation GO:0071542
The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
|
2 | Q06219 (/IDA) Q06219 (/IDA) |
Dopaminergic neuron differentiation GO:0071542
The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
|
2 | Q06219 (/TAS) Q06219 (/TAS) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
2 | Q92570 (/IGI) Q92570 (/IGI) |
Positive regulation of vascular associated smooth muscle cell migration GO:1904754
Any process that activates or increases the frequency, rate or extent of vascular associated smooth muscle cell migration.
|
2 | Q92570 (/IGI) Q92570 (/IGI) |
Negative regulation of apoptotic signaling pathway GO:2001234
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway.
|
2 | Q06219 (/ISO) Q06219 (/ISO) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
1 | Q9QZB6 (/IDA) |
Mesoderm formation GO:0001707
The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
|
1 | Q9QZB6 (/IMP) |
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
1 | Q07917 (/TAS) |
Gastrulation GO:0007369
A complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals. The details of gastrulation vary from species to species, but usually result in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
|
1 | Q9QZB6 (/IMP) |
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
1 | Q9QZB6 (/IMP) |
Pyruvate oxidation GO:0009444
The chemical reactions and pathways resulting in the conversion of pyruvate to acetylphosphate.
|
1 | Q9QZB6 (/IMP) |
Response to inorganic substance GO:0010035
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inorganic substance stimulus.
|
1 | Q07917 (/IDA) |
Positive regulation of cardiac muscle hypertrophy GO:0010613
Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
|
1 | P51179 (/IMP) |
Positive regulation of cardiac muscle hypertrophy GO:0010613
Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
|
1 | Q9QZB6 (/ISO) |
Positive regulation of glucose transmembrane transport GO:0010828
Any process that increases the frequency, rate or extent of glucose transport across a membrane. Glucose transport is the directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
1 | Q9QZB6 (/ISO) |
Response to insecticide GO:0017085
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insecticide stimulus. Insecticides are chemicals used to kill insects.
|
1 | Q07917 (/IDA) |
Hippocampus development GO:0021766
The progression of the hippocampus over time from its initial formation until its mature state.
|
1 | Q9QZB6 (/IMP) |
Adult behavior GO:0030534
Behavior in a fully developed and mature organism.
|
1 | Q9QZB6 (/IMP) |
Animal organ regeneration GO:0031100
The regrowth of a lost or destroyed animal organ.
|
1 | P51179 (/IEP) |
Positive regulation of mast cell cytokine production GO:0032765
Any process that activates or increases the frequency, rate, or extent of mast cell cytokine production.
|
1 | Q9QZB6 (/IMP) |
Spermathecum morphogenesis GO:0035211
The process in which the anatomical structures of a spermathecum, a sperm storage organ, are generated and organized. Paired spermathecae lie at the anterior end of the insect uterus on the dorsal side. Each spermatheca consists of an oval shaped capsule, connected to the uterus by a spermathecal stalk.
|
1 | P41829 (/IMP) |
Common myeloid progenitor cell proliferation GO:0035726
The multiplication or reproduction of common myeloid progenitor cells, resulting in the expansion of a cell population. A common myeloid progenitor cell is a progenitor cell committed to the myeloid lineage.
|
1 | Q9QZB6 (/IMP) |
Positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway GO:0038097
An Fc-epsilon receptor signaling pathway that results in the change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors.
|
1 | Q9QZB6 (/IMP) |
Cuticle development GO:0042335
The chemical reactions and pathways resulting in the formation of a cuticle, the outer layer of some animals and plants, which acts to prevent water loss.
|
1 | P49869 (/IMP) |
Inner ear morphogenesis GO:0042472
The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.
|
1 | Q9QZB6 (/IMP) |
Response to hydrogen peroxide GO:0042542
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | Q9QZB6 (/IMP) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | Q9QZB6 (/IMP) |
Mast cell degranulation GO:0043303
The regulated exocytosis of secretory granules containing preformed mediators such as histamine, serotonin, and neutral proteases by a mast cell.
|
1 | Q9QZB6 (/IMP) |
Response to peptide hormone GO:0043434
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
|
1 | P51179 (/IEP) |
Cellular response to leptin stimulus GO:0044320
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism.
|
1 | Q9QZB6 (/IDA) |
Cellular respiration GO:0045333
The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which either requires oxygen (aerobic respiration) or does not (anaerobic respiration).
|
1 | Q9QZB6 (/IMP) |
Positive regulation of cell cycle GO:0045787
Any process that activates or increases the rate or extent of progression through the cell cycle.
|
1 | Q9QZB6 (/IMP) |
Positive regulation of fatty acid oxidation GO:0046321
Any process that activates or increases the frequency, rate or extent of fatty acid oxidation.
|
1 | Q9QZB6 (/IMP) |
Platelet-derived growth factor receptor signaling pathway GO:0048008
The series of molecular signals generated as a consequence of a platelet-derived growth factor receptor binding to one of its physiological ligands.
|
1 | Q9QZB6 (/ISO) |
Regulation of adult chitin-containing cuticle pigmentation GO:0048082
Any process that modulates the frequency, rate or extent of establishment of the adult pattern of pigmentation in the cuticle of an organism.
|
1 | P49869 (/IGI) |
Regulation of smooth muscle cell proliferation GO:0048660
Any process that modulates the frequency, rate or extent of smooth muscle cell proliferation.
|
1 | Q9QZB6 (/ISO) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
1 | Q9QZB6 (/IMP) |
Semicircular canal morphogenesis GO:0048752
The process in which the anatomical structures of the semicircular canals are generated and organized.
|
1 | Q9QZB6 (/IMP) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
1 | Q9QZB6 (/IMP) |
Neuromuscular process controlling balance GO:0050885
Any process that an organism uses to control its balance, the orientation of the organism (or the head of the organism) in relation to the source of gravity. In humans and animals, balance is perceived through visual cues, the labyrinth system of the inner ears and information from skin pressure receptors and muscle and joint receptors.
|
1 | Q9QZB6 (/IMP) |
Vestibular reflex GO:0060005
A reflex process in which a response to an angular or linear acceleration stimulus begins with an afferent nerve impulse from a receptor in the inner ear and ends with the compensatory action of eye muscles. Signaling never reaches a level of consciousness.
|
1 | Q9QZB6 (/IMP) |
Regulation of ovulation GO:0060278
Any process that modulates the frequency, rate or extent of ovulation, the release of a mature ovum/oocyte from an ovary.
|
1 | P41829 (/IMP) |
Cellular response to catecholamine stimulus GO:0071870
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a catecholamine stimulus. A catecholamine is any of a group of biogenic amines that includes 4-(2-aminoethyl)pyrocatechol
|
1 | Q9QZB6 (/IDA) |
Energy homeostasis GO:0097009
Any process involved in the balance between food intake (energy input) and energy expenditure.
|
1 | Q9QZB6 (/IMP) |
Positive regulation of monocyte aggregation GO:1900625
Any process that activates or increases the frequency, rate or extent of monocyte aggregation.
|
1 | Q9QZB6 (/ISO) |
Positive regulation of monocyte aggregation GO:1900625
Any process that activates or increases the frequency, rate or extent of monocyte aggregation.
|
1 | P51179 (/ISS) |
Negative regulation of oxidative stress-induced neuron death GO:1903204
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced neuron death.
|
1 | Q9QZB6 (/IGI) |
Negative regulation of hydrogen peroxide-induced neuron death GO:1903208
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced neuron death.
|
1 | Q9QZB6 (/IMP) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
1 | Q9QZB6 (/ISO) |
Positive regulation of vascular associated smooth muscle cell migration GO:1904754
Any process that activates or increases the frequency, rate or extent of vascular associated smooth muscle cell migration.
|
1 | Q9QZB6 (/ISO) |
Positive regulation of leukocyte apoptotic process GO:2000108
Any process that activates or increases the frequency, rate or extent of leukocyte apoptotic process.
|
1 | Q9QZB6 (/IMP) |
Positive regulation of feeding behavior GO:2000253
Any process that activates or increases the frequency, rate or extent of feeding behavior.
|
1 | Q9QZB6 (/IMP) |
There are 17 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Nuclear speck GO:0016607
A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
|
38 |
F1D8N6 (/IDA)
F1D8N6 (/IDA)
F1D8N6 (/IDA)
F1D8N6 (/IDA)
F1D8N6 (/IDA)
F1D8N6 (/IDA)
F1D8N6 (/IDA)
F1D8N6 (/IDA)
F1D8N6 (/IDA)
F1D8N6 (/IDA)
(28 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
30 |
A0A024R126 (/IDA)
A0A024R126 (/IDA)
F5GXF0 (/IDA)
P12813 (/IDA)
P12813 (/IDA)
P22736 (/IDA)
P22736 (/IDA)
P22829 (/IDA)
P41829 (/IDA)
P43354 (/IDA)
(20 more) |
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
24 |
P22736 (/TAS)
P22736 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(14 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
18 |
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
P43354 (/TAS)
(8 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
5 | P22736 (/ISS) P22736 (/ISS) P49869 (/ISS) Q08E53 (/ISS) Q5R5Y4 (/ISS) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
5 | A0A024R126 (/IDA) A0A024R126 (/IDA) F5GXF0 (/IDA) P22736 (/IDA) P22736 (/IDA) |
Nuclear membrane GO:0031965
Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.
|
5 | A0A024R126 (/IDA) A0A024R126 (/IDA) F5GXF0 (/IDA) P22736 (/IDA) P22736 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
4 | P12813 (/ISO) P12813 (/ISO) Q06219 (/ISO) Q06219 (/ISO) |
Transcription factor complex GO:0005667
A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
|
3 | P12813 (/IDA) P12813 (/IDA) Q9QZB6 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
2 | Q92570 (/NAS) Q92570 (/NAS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | Q06219 (/ISO) Q06219 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
2 | P12813 (/ISO) P12813 (/ISO) |
Nuclear speck GO:0016607
A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
|
2 | Q06219 (/ISO) Q06219 (/ISO) |
Nuclear membrane GO:0031965
Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.
|
2 | P12813 (/ISO) P12813 (/ISO) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | P49869 (/IMP) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | Q07917 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | P49869 (/IMP) |